1. Barbet J, Chatal JF, Gauché F, Martino J (2006) Which radionuclides will nuclear oncology need tomorrow? Eur J Nucl Med Mol Imaging 33(6):627–630
2. Chatal JF (2012) this book, Chapter 5
3. Haddad F, Ferrer L, Guertin A et al (2008) ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine. Eur J Nucl Med Mol Imaging 35:1377–1387
4. Hagenbeek A, Bischof-Delaloye A, Radford JA, et al (2007) 90Y-Ibritumomab Tiuxetan (Zevalin), Consolidation of first remission in advanced stage follicular non-hodgkin′s lymphoma: first results of the international randomized phase 3 first-line indolent trial (FIT) in 414 patients. Blood 110(11): Abstract n°643, 49th annual meeting of the American society of hematology, Atlanta,8–11 Dec, 2007
5. Meunier JP, Schorsch G, Zimmermann RG (2003) La chimie au service de l’imagerie médicale (Medical imaging and chemistry). Actualité Chimique Nov–Dec: 43–56